Please visit answersincme.com/860/2026-MC-002106-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by María-Victoria Mateos, MD, PhD; and Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO. In this activity, experts in multiple myeloma discuss evidence-based strategies to personalize frontline care with anti-CD38-based quadruplets in patients with newly diagnosed myeloma. Upon completion of this activity, participants should be better able to: Identify key clinical factors that inform tailored frontline treatment approaches in patients with NDMM; Evaluate the clinical implications of key data supporting evolving frontline treatment approaches with anti-CD38–based quadruplet regimens in patients with NDMM; and Outline evidence-based strategies to integrate emerging treatment approaches into the clinical workflow of patient care in NDMM.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related